Literature DB >> 9787233

Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.

D Armstrong1, A J Augustin, R Spengler, A Al-Jada, T Nickola, F Grus, F Koch.   

Abstract

PURPOSE: To evaluate epiretinal membranes in proliferative eye disease for the presence of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-alpha).
METHODS: Membranes were surgically removed from 66 patients with proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR) and macular pucker (MP). Cytokine concentrations were determined by ELISA (VEGF) and bioassay (TNF-alpha).
RESULTS: VEGF was detected in all 66 membranes investigated. The highest VEGF values were found in patients with type I diabetes (mean = 5,994 pg/mg protein). In patients with type II diabetes, the values were at a mean of 1,242 pg/mg protein. When coagulation therapy was performed for longer than 3 months prior to surgery, VEGF was significantly (p < 0.05) reduced. Intermediate levels of VEGF were found in PVR membranes (mean = 1,417 pg/mg protein). The lowest activity was found in MP (mean = 216 pg/mg protein). In contrast, TNF-alpha was present in 16 PDR membranes, 9 PVR membranes and 8 MP membranes.
CONCLUSION: The presence of VEGF in all membranes investigated indicates that this cytokine plays an important role in angiogenesis in ischemic retinal disease and in membrane growth in proliferative disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787233     DOI: 10.1159/000027378

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  24 in total

1.  Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells.

Authors:  J Troger; S Sellemond; G Kieselbach; M Kralinger; E Schmid; B Teuchner; Q A Nguyen; E Schretter-Irschick; W Göttinger
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.

Authors:  Bojun Zhao; Gill Smith; Jun Cai; Aihua Ma; Mike Boulton
Journal:  Br J Ophthalmol       Date:  2006-08-30       Impact factor: 4.638

3.  Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy.

Authors:  B M Ben-Mahmud; W H Chan; R M Abdulahad; A Datti; A Orlacchio; E M Kohner; R Chibber
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

Review 4.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

5.  Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.

Authors:  Shiri Zayit-Soudry; Igor Vainer; Esther Zemel; Michael Mimouni; Melvin Rabena; Dante J Pieramici; Ido Perlman; Anat Loewenstein
Journal:  Doc Ophthalmol       Date:  2017-08-19       Impact factor: 2.379

6.  A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients.

Authors:  Jennifer I Lim; Christine Spee; David R Hinton
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

7.  Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.

Authors:  Eri Takahashi; Osamu Nagano; Takatsugu Ishimoto; Toshifumi Yae; Yoshimi Suzuki; Takeshi Shinoda; Satoshi Nakamura; Shinichiro Niwa; Shun Ikeda; Hisashi Koga; Hidenobu Tanihara; Hideyuki Saya
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

8.  Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit.

Authors:  Panagiotis G Theodossiadis; Vasilios S Liarakos; Petros P Sfikakis; Alexander Charonis; Georgios Agrogiannis; Nikolaos Kavantzas; Ioannis A Vergados
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-04       Impact factor: 3.117

9.  FOXO1 plays an essential role in apoptosis of retinal pericytes.

Authors:  Mani Alikhani; Sayon Roy; Dana T Graves
Journal:  Mol Vis       Date:  2010-03-10       Impact factor: 2.367

10.  Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina.

Authors:  R Nicoletti; I Venza; G Ceci; M Visalli; D Teti; A Reibaldi
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.